Log in or Sign up for Free to view tailored content for your specialty!
Neuro-Oncology News
In-house specialty pharmacy reduces medical errors, wait time
The addition of an in-house specialty pharmacy at a cancer center in Connecticut reduced the amount of time patients waited for oral cancer medications; prevented errors associated with filling, dispensing and taking oral chemotherapy; and improved overall quality of care, according to a study being presented at the Quality Care Symposium.
FDA grants breakthrough therapy designation to Toca 511 and Toca FC for high-grade glioma
The FDA granted breakthrough therapy designation to Toca 511 and Toca FC for the treatment of recurrent high grade glioma, according to the drugs’ manufacturer.
Log in or Sign up for Free to view tailored content for your specialty!
Improvements needed to better integrate PCPs into cancer survivorship care
Several cancer survivorship care models are available to help integrate primary care providers into the long-term follow-up care of cancer survivors.
Many patients lack knowledge about advances in cancer diagnostics, treatment
A majority of patients with cancer and their caregivers lack sufficient knowledge about advances in diagnostic and treatment options, according to results of a survey released by Cancer Treatment Centers of America.
Many nonelderly cancer survivors alter prescription drug use to save money
Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in Cancer.
Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results.
BERG initiates trial of BPM 31510-IV for glioblastoma
BERG LLC has initiated a phase 1/phase 2 clinical trial to evaluate BPM 31510-IV as monotherapy for patients with glioblastoma multiforme.
FDA: More adolescents with cancer should be included in adult trials
Enrollment of adolescents in oncology trials remains significantly lower than that of children.
Use of metaphors may improve participation in clinical trials
The use of metaphors for explaining randomization could ease the difficulty in recruiting patients to participate in randomized clinical trials, according to a study published in the Journal of the National Cancer Institute.
‘Explosive growth’ of interventional oncology prompts formation of new society
The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established a society to further its mission.